Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

ADIPOQ antibody (N-Term)

This anti-ADIPOQ antibody is a Rabbit Polyclonal antibody detecting ADIPOQ in IHC. Suitable for Human and Mouse. This Primary Antibody has been cited in 3+ publications.
Catalog No. ABIN965514

Quick Overview for ADIPOQ antibody (N-Term) (ABIN965514)

Target

See all ADIPOQ Antibodies
ADIPOQ (Adiponectin (ADIPOQ))

Reactivity

  • 157
  • 64
  • 48
  • 22
  • 14
  • 7
  • 5
  • 5
  • 2
  • 1
  • 1
Human, Mouse

Host

  • 153
  • 89
  • 5
  • 2
  • 2
  • 1
  • 1
Rabbit

Clonality

  • 155
  • 96
Polyclonal

Conjugate

  • 156
  • 36
  • 19
  • 8
  • 7
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This ADIPOQ antibody is un-conjugated

Application

  • 174
  • 122
  • 104
  • 72
  • 65
  • 34
  • 33
  • 17
  • 14
  • 12
  • 10
  • 8
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunohistochemistry (IHC)
  • Binding Specificity

    • 22
    • 13
    • 8
    • 8
    • 7
    • 7
    • 6
    • 6
    • 5
    • 5
    • 4
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 55-69, N-Term

    Purification

    Purified by antigen-specific affinity chromatography.

    Immunogen

    Polyclonal antibody produced in rabbits immunizing with a synthetic peptide corresponding to residues 55-69 of human ADIPOQ(Adiponectin precursor)
  • Application Notes

    ELISA, Western blotting: 1µg/ml for 2hrs.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    This antibody is stored in PBS, 50% glycerol

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C
  • Arita, Kihara, Ouchi, Takahashi, Maeda, Miyagawa, Hotta, Shimomura, Nakamura, Miyaoka, Kuriyama, Nishida, Yamashita, Okubo, Matsubara, Muraguchi, Ohmoto, Funahashi, Matsuzawa: "Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity." in: Biochemical and biophysical research communications, Vol. 257, Issue 1, pp. 79-83, (1999) (PubMed).

    Saito, Tobe, Minoshima, Asakawa, Sumiya, Yoda, Nakano, Shimizu, Tomita: "Organization of the gene for gelatin-binding protein (GBP28)." in: Gene, Vol. 229, Issue 1-2, pp. 67-73, (1999) (PubMed).

    Schäffler, Orsó, Palitzsch, Büchler, Drobnik, Fürst, Schölmerich, Schmitz et al.: "The human apM-1, an adipocyte-specific gene linked to the family of TNF's and to genes expressed in activated T cells, is mapped to chromosome 1q21.3-q23, a susceptibility locus identified for ..." in: Biochemical and biophysical research communications, Vol. 260, Issue 2, pp. 416-25, (1999) (PubMed).

  • Target

    ADIPOQ (Adiponectin (ADIPOQ))

    Alternative Name

    ADIPOQ

    Background

    ADIPOQ (Adiponectin) is an important negative regulator in hematopoiesis and immunesystems. ADIPOQ may be involved in ending inflammatory responses through its inhibitory functions. ADIPOQ inhibits endothelial NF-kappa-B signaling through a cAMP-dependent pathway. It inhibits TNF-alpha-induced expression of endothelial adhesion molecules. ADIPOQ is involved in the control of fat metabolism and insulin sensitivity. Defects in ADIPOQ are the cause of adiponectin deficiency. The result is a very low concentration of plasma adiponectin. The decreased adiponectin plasma levels are associated with obesity insulin resistance, and diabetes type 2.
You are here:
Chat with us!